1、投稿方式：在线投稿。

2、刊内网址：

http://www.maternal-fetalmedicine.org（202302期）

自动跳转至：

https://journals.lww.com/mfm/pages/default.aspx

3、投稿系统：

https://www.editorialmanager.com/mfm/default.aspx

4、中华医学会期刊主页：

https://mednexus.org/journal/mfm

（从中华医学期刊网https://www.medjournals.cn进入）

5、出刊日期：季刊，逢季首月25日出版。

2023年7月28日星期五

《母胎医学杂志（英文）》投稿须知

【官网信息】

投稿须知：https://edmgr.ovid.com/mfm/accounts/ifauth.htm

INSTRUCTIONS FOR AUTHORS

The

Editorial Office is pleased to answer any questions you may have about

preparing your manuscript in accordance with the guidelines.

E-mail: mfm@cmaph.org, mfmedicine@126.com

AIMS AND SCOPE

Maternal-Fetal

Medicine (MFM) is a newly launched international peer-reviewed journal

of the Chinese Medical Association. The aim of the journal is to publish

high quality scientific articles in all areas of Obstetrics and

Maternal-Fetal Medicine, including original clinical and translational

research, state-of-the-art reviews, commentaries, case studies and case

reports, and letters to the editor. Articles are published quarterly.

The journal is available both in print and online.

Areas covered include but not limited to:

Medical complications of pregnancy

Adverse events of pregnancy

Fetal development

Prenatal screening and diagnosis

Fetal Treatment and Therapy

Technology and developments in the field of Obstetrics and Maternal-Fetal Medicine

ONLINE SUBMISSION

All manuscripts must be submitted online through the website:

https://www.editorialmanager.com/mfm

First-time

users will have to register at this site. Registration is free but

mandatory. Registered authors can keep track of their articles after

logging into the site using their username and password. Authors do not

have to pay for submission of articles. If you experience any problems,

please contact the editorial office by E-mail: mfm@cmaph.org;

mfmedicine@126.com.

JOURNAL POLICIES

DUPLICATE PUBLICATION

Manuscripts

are reviewed for possible publication with the understanding that they

are being submitted only to MFM and have not been published,

simultaneously submitted, or already accepted for publication elsewhere.

The Editorial team may subject any manuscript submitted for

consideration of publication in MFM to plagiarism-detection software.

This

does not preclude consideration of a manuscript that has been rejected

by another journal or a complete report that follows publication of

preliminary findings elsewhere, usually in the form of an abstract.

Copies of any possibly duplicate published material should be submitted

with the manuscript under consideration, with a statement in the cover

letter as to why the manuscript currently being submitted is not a

duplicate publication.

DISCLOSURE OF CONFLICTS

Authors

must state all possible conflicts of interest in the manuscript,

including financial, consultant, institutional and other relationships

that might lead to bias or a conflict of interest. If there is no

conflict of interest, this should also be explicitly stated as none

declared. All sources of funding should be acknowledged in the

manuscript. All relevant conflicts of interest and sources of funding

should be included on the title page of the manuscript with the heading

"Conflicts of Interest and Source of Funding:" For example: “Conflicts

of Interest and Source of Funding: A has received honoraria from Company

Z. B is currently receiving a grant (#12345) from Organization Y, and

is on the speaker's bureau for Organization X - the CME organizers for

Company A. For the remaining authors, no relevant conflicts of interest

were declared.”

Financial Support and Competing Interests

A

financial disclosure section is part of the submission process and must

be completed by each author at submission. This information is for

review by the Editors but will be published if relevant to the content

of the accepted manuscript.

The

primary purpose of the disclosure section is to determine whether

authors have received any commercial financial support that could create

a conflict of interest. In addition to monetary interests, a potential

for conflict of interest can exist whether or not an individual believes

that a relationship (such as dual commitments, competing interests, or

competing loyalties) affects his or her scientific judgment. Please

review ICMJE Uniform Requirements for Manuscripts.

AUTHORSHIP

MFM

expects that each person listed as an author has participated

suffi­ciently in the intellectual content, the analysis of data, and/or

the writing of the manuscript to take public responsibility for it. Each

author must have reviewed the manuscript, believes it represents valid

work, and approves it for submission.

Moreover,

should the Editorial team request the data upon which the manuscript is

based, the authors shall provide the data. Each author’s specific

contributions to the work should be indicated; this information will be

published as a footnote to the paper. For example, the areas of

participation might include:

Participated in research design

Participated in the writing of the paper

Participated in the performance of the research

Contributed new reagents or analytic tools

Participated in data analysis

An

author may list more than one contribution, and more than one author

may have contributed to the same aspect of the work. Any change in

authorship/contributions after submission must be approved in writing by

all authors and submitted to the Editorial Office for final

consideration.

RETRACTION POLICY

MFM should consider retracting a publication if:

Editors

have clear evidence that the findings are unreliable, either as a

result of misconduct (e.g., data fabrication) or honest error (e.g.,

miscalculation or experimental error).

The

findings have previously been published elsewhere without proper

crossreferencing, permission or justification (i.e., cases of redundant

publication).

It constitutes plagiarism.

It reports unethical research.

MFM

abides by Retraction Guidelines of the Committee on Publication Ethics

(COPE)

(http://publicationethics.org/files/retraction%20guidelines_0.pdf).

等等……